Rapid effectiveness of certolizumab pegol in non-radiographic axial spondyloarthritis

被引：0
|
作者：
Spadaro, A. [1 ]
Scarno, A. [1 ]
Carboni, A. [1 ]
Perrotta, F. M. [1 ]
Catalano, C. [2 ]
Lubrano, E. [3 ]
Valesini, G. [1 ]
机构：
[1] Univ Roma La Sapienza, UOC Reumatol, Dipartimento Med Interna & Specialita Med, Rome, Italy
[2] Univ Roma La Sapienza, Radiol Cent UOC A, Dipartimento Med Mol, Rome, Italy
[3] Univ Molise, Dipartimento Med & Sci Salute, Campobasso, Italy
来源：
REUMATISMO | 2013年 / 65卷 / 03期
关键词：
Certolizumab pegol; Axial spondyloarthritis; Magnetic resonance;
D O I：
10.4081/reumatismo.2013.134
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In axial spondyloarthritis (SpA), the efficacy of certolizumab pegol (CZP), a novel pegylated anti-tumor necrosis factor alpha drug has not been investigated. We report that CZP showed a rapid effectiveness, assessed clinically and by magnetic resonance imaging, in a patient with a non-radiographic axial SpA, classified according to Assessment in SpondyloArthritis International Society (ASAS) criteria. This case suggests that CZP could be considered an useful treatment in non-radiographic axial SpA, supporting that an earlier therapeutic approach could play a relevant role in the management of the disease.
引用
收藏
页码：134 / 137
页数：4
相关论文
共 50 条
  • [21] Certolizumab Pegol Efficacy in Patients with Non-Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C-Reactive Protein Status
    Deodhar, Atul
    Gensler, Lianne
    Hall, Stephen
    Robinson, Philip
    Hoepken, Bengt
    Bauer, Lars
    Kumke, Thomas
    Maksymowych, Walter
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [22] Radiographic progression in non-radiographic axial spondyloarthritis
    Protopopov, Mikhail
    Poddubnyy, Denis
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (06) : 525 - 533
  • [23] The Concept of Non-Radiographic Axial Spondyloarthritis
    Kiltz, U.
    Baraliakos, X.
    Braun, J.
    [J]. AKTUELLE RHEUMATOLOGIE, 2013, 38 (02) : 92 - 96
  • [24] Reduction Of Disease Burden On Workplace and Household Productivity In Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis, Over 48 Weeks Of Treatment With Certolizumab Pegol
    van der Heijde, Desiree M.
    Braun, Juergen
    Rudwaleit, Martin
    Purcaru, Oana
    Kavanaugh, Arthur
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S644 - S645
  • [25] Adalimumab In Non-Radiographic Axial Spondyloarthritis
    Burness, Celeste B.
    Deeks, Emma D.
    [J]. DRUGS, 2012, 72 (18) : 2385 - 2395
  • [26] Non-radiographic axial spondyloarthritis: what is it?
    Fianyo, E.
    Wendling, D.
    Poulain, C.
    Farrenq, V.
    Claudepierre, P.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (01) : 1 - 4
  • [27] AdalimumabIn Non-Radiographic Axial Spondyloarthritis
    Celeste B. Burness
    Emma D. Deeks
    [J]. Drugs, 2012, 72 : 2385 - 2395
  • [28] The burden of non-radiographic axial spondyloarthritis
    Boonen, Annelies
    Sieper, Joachim
    van der Heijde, Desiree
    Dougados, Maxime
    Bukowski, Jack F.
    Valluri, Satish
    Vlahos, Bonnie
    Kotak, Sameer
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2015, 44 (05) : 556 - 562
  • [29] Challenges in non-radiographic axial spondyloarthritis
    Poddubnyy, Denis
    [J]. JOINT BONE SPINE, 2023, 90 (01)
  • [30] LONG-TERM SAFETY AND EFFICACY OF CERTOLIZUMAB PEGOL IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 96-WEEK OUTCOMES OF THE RAPID-AXSPA TRIAL
    Sieper, J.
    Rudwaleit, M.
    van der Heijde, D.
    Maksymowych, W.
    Dougados, M.
    Mease, P. J.
    Braun, J.
    Deodhar, A.
    Hoepken, B.
    Nurminen, T.
    Landewe, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 719 - 720
12345